HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study.

AuthorsA Rao, C Bunker
JournalThe British journal of dermatology (Br J Dermatol) Vol. 163 Issue 1 Pg. 208; author reply 208-9 (Jul 2010) ISSN: 1365-2133 [Electronic] England
PMID20353455 (Publication Type: Comment, Letter)
Chemical References
  • Immunosuppressive Agents
  • Ointments
  • Betamethasone Valerate
  • Tacrolimus
Topics
  • Betamethasone Valerate (therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Ointments
  • Paronychia (drug therapy)
  • Randomized Controlled Trials as Topic
  • Tacrolimus (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: